Articles tagged with Peptides
Researchers at St. Jude Children's Research Hospital discovered that toxic peptides from ALS and FTD can incapacitate membrane-less organelles, leading to tissue degeneration. The study provides new insights into the molecular mechanisms of these debilitating diseases.
Long-term clinical data supports the efficacy of PRRT in treating neuroendocrine tumors, improving tumor response rates and progression-free survival. To minimize toxicity, steps such as timing of therapy, patient selection criteria, dose optimization, and adequate monitoring can be taken.
Researchers develop genetically engineered peptides to transmit information between biological systems and synthetic materials, enabling a coherent bioelectronic interface. The discovery enables the creation of biomolecular solid-state devices with potential applications in biomedical and electro-optical devices.
Scientists have created peptide-based materials that can reorganize their sequences to adapt to their environment, paving the way for new product possibilities including drug delivery, food science, and cosmetics. The method allows for unbiased discovery of optimized structures through self-selection.
New research points to relaxin-3 as a potential treatment target for mental illnesses like depression and anxiety. Developments in peptide technology could lead to selectively targeting RXFP3 to develop new class of drugs.
Researchers have discovered a key substance called EPFL2 that creates plant teeth and found out how they work. The peptide inhibits the accumulation of auxin at the skirts of tooth tips, preventing the generation of leaf teeth in plants that are unable to make EPFL2.
Scientists have discovered unique genome variants linked to cancer development, which can be used to detect weaknesses in tumor cells. The new approach uses proteogenomics and mass spectrometry data to identify variant peptides, providing valuable information for gene annotation and potential drug targets.
Researchers at IRB Barcelona have made significant advances in developing shuttle peptides that can transport drugs across the blood-brain barrier. These peptide vectors show promise for treating neurological diseases with improved efficiency and lower side effects.
After major trauma, debris from damaged cell powerhouses triggers an immune response in the kidneys, leading to permanent damage or destruction. Researchers aim to prevent this by understanding how formyl peptide receptors activate the immune system.
An international research team identified a signal peptide required for awn elongation in wild rice and found its dysfunction in cultivated Asian rice. The study suggests human selection pressure led to the loss of this peptide's function, resulting in awnlessness.
A team of Danish researchers has developed a new method for creating artificial proteins by combining oligonucleotides and peptides. This breakthrough could lead to better treatments for diseases like cancer and diabetes, as well as improved control over protein properties.
A European and US research team has successfully determined the structure of the most disease-relevant beta-amyloid peptide 1–42 fibrils at atomic resolution. The findings simplify the targeted search for drugs to treat Alzheimer's dementia, offering hope for a potential cure in the next decade.
A new analytical tool for detecting double-stranded RNA (dsRNA) has been developed, exhibiting sequence-selective fluorescence upon binding. This probe offers a significant improvement over conventional methods by allowing single-base pair resolution and preferential binding to dsRNA over dsDNA.
Researchers have developed iron catalysts that can diversify chiral amino acids into 21 different structures while preserving their handedness. This technology allows for the creation of modified peptides or entirely new structures, expanding the pool of unnatural chiral amino acids available to researchers.
Researchers found that tomatoes can detect a parasitic vine's peptide, triggering an immune response and increased resistance. This discovery could lead to new strategies for mitigating crop losses caused by parasitic plants worldwide.
Researchers explore cyclic opioid peptides with constrained topographical structure, offering improved affinities and selectivities at target receptors. The benefits of cyclization have been enhanced through the generation of polycyclic peptides, promoting increased stability and therapeutic potential for novel therapeutics.
Scientists developed a novel peptide that protects cognitive function after mild traumatic brain injury by reducing inflammation, cell death, and cognitive impairments in mice. The peptide, called TXM-peptide, mimics the antioxidant activity of thioredoxin and inhibits the inflammatory pathway.
Researchers at EMBL-EBI develop an algorithm to cluster peptide mass spectra, identifying 9 million consistently unidentified spectra. This breakthrough simplifies the detection of post-translational modifications and variants, paving the way for more efficient exploitation of proteomics data.
Scientists at Sanford Burnham Prebys Medical Discovery Institute have discovered a peptide sequence that can carry molecules and nanoparticles to acutely damaged areas of the brain, providing a new means of delivering therapeutics for traumatic brain injuries. This technology has the potential to minimize the effects of secondary injur...
Scientists have isolated two small peptides from crop species that show effective antimicrobial effects on bacteria implicated in food spoilage and poisoning. These peptides, similar to a human peptide used to guard against beer-spoiling bacteria, offer a promising new approach to combatting antibiotic resistance.
Researchers at Rice University have created 'missing tooth' hydrogels that can trap and slowly release hydrophobic small-molecule drugs, making them ideal for targeted delivery. The biodegradable gel can be injected where needed and releases medication over time.
Scientists have developed a set of universal protein tags that enable accurate quantification of proteins using targeted proteomics techniques. The new tags, named PQS, are designed to work with selective reaction monitoring (SRM) and eliminate the need for labor-intensive assay development.
Researchers at RIKEN discovered that acrolein can combine with polyamines to form substances that prevent the aggregation of amyloid-beta peptides, a process linked to Alzheimer's disease. The findings suggest that acrolein may have an anti-fibrillation effect, potentially influencing the progression of neurological disorders.
Scientists developed an approach for non-invasive testing of pregnant women with preeclampsia, identifying potential peptide biomarkers in their urine. The study found 35 potential biomarkers associated with the condition's severity.
Researchers reviewed scientific evidence on fermented milk's antihypertensive effects and identified opportunities to develop functional foods based on new lactic acid bacteria. The study found that some strains of Lactobacillus helveticus can reduce blood pressure, but more research is needed to confirm this.
Researchers discovered a new vulnerable site on HIV called the fusion peptide, which has a simpler structure than other sites studied. A broadly neutralizing antibody targeting this site could help prevent HIV infection by binding to key cell-surface molecules.
TP508 has significantly increased survival and delayed mortality when injected up to 24 hours after lethal radiation exposure in controlled preclinical studies. The award brings total NIAID funding to over $6M and allows Chrysalis to complete FDA approval studies.
Researchers investigate the interaction of nucleotide chains with metallic nanoparticles in carbon nanotubes using hybrid molecular dynamics simulation methods. The study highlights the potential of these systems for designing electronic diagnostic tools and drug delivery systems.
Researchers at University of Guelph found that soy isoflavones and peptides can effectively inhibit the growth of certain bacterial pathogens, including Listeria and Pseudomonas. This natural alternative could benefit the food industry by reducing reliance on synthetic additives and addressing growing concerns about antibiotic resistance.
Researchers at the Medical University of South Carolina discovered that the M10 peptide protects against fibrotic damage in a mouse model of ILD and is likely due to its modulation of the TGF-β1 pathway. The anti-fibrotic effects of M10 may also be effective in treating other forms of pulmonary fibrosis.
The novel blood test detects misfolded Amyloid beta peptides in body fluids, revealing potential for early detection of Alzheimer's. The test has achieved high diagnostic precision with a sensitivity of up to 90% and is being further optimized in ongoing studies.
Researchers developed a new imaging technique that uses tagged peptides to track gelatinase activity in stroke patients. This method may lead to better understanding of how to treat strokes and prevent brain damage. The study was published in the Journal of Cerebral Blood Flow and Metabolism.
Researchers at Lomonosov Moscow State University discovered the key trigger of Alzheimer's disease development, involving zinc ions and peptide aggregation. They propose a mechanism for transforming healthy peptides into toxic ones, paving the way for new medicine to block beta-amyloid peptide aggregation.
Researchers convert tarantula toxins into painkillers by targeting neural receptors, providing an alternative to current treatments with limited pain relief and side effects. The study reveals the importance of cell membranes in peptide toxin activity and opens opportunities for designing new drugs.
Researchers are developing longer-lived imaging agents to target soluble oligomers, a potentially neurotoxic form of amyloid beta peptide. This approach may lead to more accurate diagnoses and better understanding of the disease process.
Researchers at the Advanced Science Research Center have developed tunable peptide emulsifiers with biocompatible and biodegradable properties. These peptides can form oil-in-water emulsions with varying stability under different environmental conditions.
Researchers have identified antigens that activate autoreactive T cells in autoimmune diabetes, a potential trigger for the disease. The discovery provides insight into how the immune system is tricked into destroying the body's own beta cells.
Researchers identified hybrid insulin peptides (HIPs) that trigger autoimmune response in T1D patients, prompting immune system to attack insulin-producing cells. These findings may help explain the mystery of why people with T1D are affected by incorrect insulin peptide bonding.
Researchers at IRB Barcelona have synthesized peptides that target the Epidermal Growth Factor (EGF) protein, which accelerates tumour cell growth. These peptides show promise as a potential treatment for cancer, and further studies are underway to develop stronger compounds.
McGill researchers have taken 3D images of a large section from a medicine-synthesizing enzyme in action. The images reveal the intricate way these proteins function and could lead to the development of new antibiotics. This breakthrough may bring scientists closer to understanding how many antibiotics are made.
Researchers at Salk Institute identify nuclear factor kB as a key player in glioblastoma multiforme proliferation. Targeting this protein with NBD peptide or Timp1 gene slows tumor growth and increases mouse survival time, offering potential new treatment avenues.
A study published in the Biophysical Journal reveals a hepatitis C virus-derived peptide that kills a range of viruses while leaving host cells unharmed. The peptide targets cholesterol-rich membranes shared by many viruses, offering a promising strategy for developing new antiviral drugs.
Researchers at Penn State University have developed a system to replicate the formation and dissolution of liquid organelles in a lab setting. By controlling the electrostatic charge of molecules, they were able to create synthetic liquid organelles that can assemble and disassemble in a biologically-reasonable way.
A short peptide, SKY peptide, has been developed by researchers at LMU to inhibit the activation of a signal pathway in monocytes, which enables their adhesion to endothelial cells and penetration into sites of acute inflammation. This can lead to chronic inflammatory reactions and tissue damage.
Researchers at UMass Amherst have identified a key molecule in nitrogen-fixing bacteria that may hold promise for improving crop yields without increasing fertilizer use. The discovery of the 'double agent' peptide could be a key factor in future efforts to improve legume crops and promote sustainable farming practices.
A novel immunotherapeutic approach, personalized peptide vaccination, showed significant improvement in overall survival for patients with advanced bladder cancer. The study found a median overall survival of almost twice as long as that for patients without the treatment, at 7.9 months versus 4.1 months.
Researchers at the University of California, San Diego, have developed a simple way to send peptides into cells and tissues. The new method uses a densely packed brush to protect peptides from digestion and enhance their ability to enter cells without altering their biological function.
Researchers discovered peptides that inhibit metastatic spreading and even lead to regression of existing metastases in pancreatic cancer models. The CD44v6 protein drives the spread of tumor cells, but small segments of the protein can be successfully inhibited by peptides.
Researchers developed a new method that identifies more proteins and peptides in mass spectrometry data, analyzing pairs of overlapping peptide spectra. The method improves performance by up to four-fold, overcoming the bottleneck created by vast amounts of raw data.
Researchers at University of the Pacific have developed a method to significantly extend the lifespan of peptides. By tagging peptides with a compound, they enable it to survive in the bloodstream longer and avoid degradation. This breakthrough technology has the potential to improve peptide therapies for cancer and other diseases.
University of Missouri researchers have created a biodegradable active layer in organic electronics using peptides, enabling full biodegradability. The discovery could significantly reduce electronic waste in landfills and minimize health risks associated with e-waste exposure.
A recent animal study broadens understanding of the flu virus's impact on the immune system, revealing a more dynamic process that engages multiple biological pathways. This research may lead to the development of more effective vaccines against influenza and other viruses.
Researchers at Queen Mary University of London developed a method for self-assembling organic molecules into complex tissue-like structures without moulds or 3D printing. This discovery could enable the engineering of tissues like veins, arteries, or the blood-brain barrier, facilitating disease research and implant development.
Researchers have identified a new protein fragment, amyloid-η, which antagonizes the hyperactive effect of beta-amyloid on nerve cells. This finding has immediate implications for ongoing clinical trials targeting beta-amyloid, suggesting that unanticipated side-effects may occur if eta-amyloid levels increase
Researchers are developing 3D-printed biodegradable polymer scaffolds to accelerate bone growth in head and neck injuries. The technology has the potential to produce mechanically strong replaced bone with minimal inflammation and within a short healing period.
A new peptide drug, TP508, has been shown to significantly increase survival in mice when administered 24 hours after nuclear radiation exposure. The study found that the drug counteracts damage to the gastrointestinal system, delaying mortality and increasing chances of survival.
Researchers found that comet impacts can synthesize peptides, the first building blocks of life, under cold conditions. This suggests that comet impacts played a crucial role in delivering life's seeds to early Earth.
Researchers have developed a new probe that can detect blood clots in any part of the body using positron emission tomography (PET). The probe, called FBP8, contains copper-64 and has shown promise in detecting blood clots in rats, paving the way for future human trials.
Researchers at Toyohashi University of Technology developed new agents to inhibit the production of amyloid-beta peptides, a main cause of Alzheimer's disease. The novel curcumin derivatives were proposed through molecular simulations and shown to bind strongly to amyloid precursor protein.
Researchers have developed a method to increase nitric oxide production in nasal passages, which is linked to chronic sinusitis. The approach involves boosting NO levels using low-molecular-weight peptides that were created from an already-approved drug compound.